Cargando…
A Comparison of the α2/3/5 Selective Positive Allosteric Modulators L-838,417 and TPA023 in Preclinical Models of Inflammatory and Neuropathic Pain
GABA(A) receptors containing α2/3 subunits are current targets in the battle to develop new pain medications, as they are expressed in the spinal cord where increasing inhibitory drive should result in analgesia. However, this approach is prone to a range of side effects including sedation, cognitiv...
Autores principales: | Nickolls, Sarah, Mace, Hannah, Fish, Rebecca, Edye, Michelle, Gurrell, Rachel, Ivarsson, Magnus, Pitcher, Tom, Tanimoto-Mori, Sachi, Richardson, Denise, Sweatman, Catherine, Nicholson, Janet, Ward, Cameron, Jinks, John, Bell, Christine, Young, Kimberly, Rees, Huw, Moss, Andrew, Kinloch, Ross, McMurray, Gordon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226534/ https://www.ncbi.nlm.nih.gov/pubmed/22162674 http://dx.doi.org/10.1155/2011/608912 |
Ejemplares similares
-
838. Oral Vancomycin Prophylaxis Works!
por: Van Hise, Nicholas W, et al.
Publicado: (2019) -
The α2/α3GABA(A) receptor modulator TPA023B alleviates not only the sensory but also the tonic affective component of chronic pain in mice
por: Neumann, Elena, et al.
Publicado: (2021) -
Séminaire Bourbaki : exposés 400–417
por: Dold, A, et al.
Publicado: (1973) -
TPA-023 attenuates subchronic phencyclidine-induced declarative and reversal learning deficits via GABA(A) receptor agonist mechanism: possible therapeutic target for cognitive deficit in schizophrenia
por: Rajagopal, Lakshmi, et al.
Publicado: (2018) -
Vous cherchez? (PRESSCUT-S-2006-023)
Publicado: (2006)